These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds. Errami A; Baghdadi JE; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Rada N; Benajiba N; Mokhantar K; Ouazahrou K; Zaidi S; Abel L; Casanova JL; Boisson-Dupuis S; Bustamante J; Bousfiha AA J Clin Immunol; 2023 May; 43(4):728-740. PubMed ID: 36630059 [TBL] [Abstract][Full Text] [Related]
7. Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease. Zhou X; Jia W; Ni Z; Wang A; Liu Z; Hou M; Zhou M; Tang Z; Zhang D; Li L; Han T; Tan Y; Luo G; Wang J; Wu Y; Zhang X PLoS One; 2019; 14(4):e0215648. PubMed ID: 30998751 [TBL] [Abstract][Full Text] [Related]
8. Autosomal recessive Abdelmajeed O; Ali MMD; Erwa NH; Mustafa A; Ahmed YA; Ahmed RHA; Mohammed HHE; Hassan ME; Ahmed M; Algam S Front Immunol; 2023; 14():1135824. PubMed ID: 37063912 [TBL] [Abstract][Full Text] [Related]
9. Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases. Ono R; Tsumura M; Shima S; Matsuda Y; Gotoh K; Miyata Y; Yoto Y; Tomomasa D; Utsumi T; Ohnishi H; Kato Z; Ishiwada N; Ishikawa A; Wada T; Uhara H; Nishikomori R; Hasegawa D; Okada S; Kanegane H J Clin Immunol; 2023 Feb; 43(2):466-478. PubMed ID: 36336768 [TBL] [Abstract][Full Text] [Related]
11. Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases. Bustamante J; Picard C; Boisson-Dupuis S; Abel L; Casanova JL Ann N Y Acad Sci; 2011 Dec; 1246():92-101. PubMed ID: 22236433 [TBL] [Abstract][Full Text] [Related]
12. Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China. Ying W; Liu D; Dong X; Wang W; Hui X; Hou J; Yao H; Zhou Q; Sun B; Sun J; Wang X J Clin Immunol; 2019 Aug; 39(6):600-610. PubMed ID: 31367980 [TBL] [Abstract][Full Text] [Related]
13. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review. Khavandegar A; Mahdaviani SA; Zaki-Dizaji M; Khalili-Moghaddam F; Ansari S; Alijani S; Taherzadeh-Ghahfarrokhi N; Mansouri D; Casanova JL; Bustamante J; Jamee M J Allergy Clin Immunol; 2024 May; 153(5):1432-1444. PubMed ID: 38341181 [TBL] [Abstract][Full Text] [Related]
14. A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients. Ben-Mustapha I; Ben-Ali M; Mekki N; Patin E; Harmant C; Bouguila J; Elloumi-Zghal H; Harbi A; Béjaoui M; Boughammoura L; Chemli J; Barbouche MR Immunogenetics; 2014 Jan; 66(1):67-71. PubMed ID: 24127073 [TBL] [Abstract][Full Text] [Related]
15. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease. Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640 [TBL] [Abstract][Full Text] [Related]
16. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients. Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053 [TBL] [Abstract][Full Text] [Related]
17. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease. Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293 [TBL] [Abstract][Full Text] [Related]
18. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. Filipe-Santos O; Bustamante J; Haverkamp MH; Vinolo E; Ku CL; Puel A; Frucht DM; Christel K; von Bernuth H; Jouanguy E; Feinberg J; Durandy A; Senechal B; Chapgier A; Vogt G; de Beaucoudrey L; Fieschi C; Picard C; Garfa M; Chemli J; Bejaoui M; Tsolia MN; Kutukculer N; Plebani A; Notarangelo L; Bodemer C; Geissmann F; Israël A; Véron M; Knackstedt M; Barbouche R; Abel L; Magdorf K; Gendrel D; Agou F; Holland SM; Casanova JL J Exp Med; 2006 Jul; 203(7):1745-59. PubMed ID: 16818673 [TBL] [Abstract][Full Text] [Related]
19. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India. Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM Front Immunol; 2021; 12():631298. PubMed ID: 33732252 [TBL] [Abstract][Full Text] [Related]
20. Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity. Dolezalova K; Strachan T; Matej R; Ricna D; Bloomfield M Eur J Dermatol; 2022 Sep; 32(4):495-504. PubMed ID: 36069176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]